Paushak standalone net profit rises 12.80% in the June 2024 quarter

💎जैन सा'ब के GEMS ... 

आज Paushak Limited को क्यों चुना संदीप जैन ने? 

संदीप जैन से जानिए कंपनी के फंडामेंटल्स, तेजी के ट्रिगर्स और टार्गेट...  

#sandeepjain  #anilsinghvi  #stockstobuy  #stockmarket  




About Zee Business:

Zee Business is India's Number 1 Hindi business news channel. It's your channel for profit and wealth. Watch Live coverage of Indian markets - Sensex & Nifty, also for expert insights and advise from our team of experts.
 
--------------------------------------------------------------
Subscribe Zee Business: https://bit.ly/3L6GG0C
 
You Can Also Visit Our Website at: 

Zee Business: https://www.zeebiz.com/
Zee News: https://zeenews.india.com/
DNA India:-https://www.dnaindia.com/
WION: https://www.wionews.com/ 

Follow Us On: 
  
Facebook: https://goo.gl/OMJgrn
Twitter: https://goo.gl/OjOzpB 
Download Zee News App : https://bit.ly/ZeeNewsApps

Paushak Limited : Company's Fundamentals, & Target By Sandeep Jain | Jain Saab Ke Gems

Paushak standalone net profit rises 109.19% in the December 2022 quarter

Paushak standalone net profit rises 294.20% in the June 2022 quarter

United Spirits, Hero MotoCorp, EID Parry (India), Paushak and Unichem Laboratories will have their annual general meetings (AGM) today.The board of eClerx Services will meet today to consider a bonus issue while the board of JBM Auto and Capacit’e Infraprojects will meet today to consider a preferen…

Corporate Radar: ABB India, MRF Q1 results; United Spirits, Hero MotoCorp AGMs, and more

Acrysil Ltd, Dr Lal Pathlabs Ltd, Paushak Ltd and Delta Corp Ltd are among the other losers in the BSE’s ‘A’ group today, 18 May 2022.

Metropolis Healthcare Ltd leads losers in ‘A’ group

Tata Steel Long Products Ltd, Paushak Ltd, Persistent Systems Ltd and India Glycols Ltd are among the other losers in the BSE’s ‘A’ group today, 20 April 2022.

Larsen & Toubro Infotech Ltd leads losers in ‘A’ group

“If a company as big as Asian Paints or a Pidilite compounds profits at 15% but cash flows at 25%, it is the cash flow compounding which is driving the stock. Optically the PE multiple will look high because the P is not following E. The P is following free cash flow. ”

Vmart Share Price | Paushak Share Price: Follow cash & not PAT to make good money in India: Saurabh Mukherjea

The macroeconomic outlook in India is as clear as it can be as demand is outstripping supply, believes Saurabh Mukherjea of Marcellus Investment Managers. Speaking to ET NOW, Mukherjea said that there has been demand recovery across sectors from mid-January onwards. He believes the Ukraine crisis will lead to consolidation in market leaders’ favour. Among sectors, he said that no hotel or multiplex has generated free cash flow. Among new-age companies, he believes Nykaa to be the best of the lot. He said he is still looking at Reliance Industries cautiously before investing. He has built a position in Paushak and has been buying Asian Paints. Pharma ancillaries and FMCG ancillaries are seeing consolidation, can look at fine organics, Galaxy Surfactants, he added. Watch.
Subscribe To ET Now For Latest Updates On Stocks, Business, Trading | ► https://goo.gl/SEjvK3

Subscribe Now To Our Network Channels :-
Times Now  : http://goo.gl/U9ibPb
The NewsHour Debate : http://goo.gl/LfNgFF

To Stay Updated Download the Times Now App :-
Android Google Play :  https://goo.gl/zJhWjC
Apple App Store :  https://goo.gl/d7QBQZ

Social Media Links :-
Twitter - http://goo.gl/hA0vDt
Facebook - http://goo.gl/5Lr4mC
G+ - http://goo.gl/hYxrmj
Website - www.etnownews.com

Finding The Alpha In A Volatile Market | Saurabh Mukherjea

Paushak standalone net profit declines 37.78% in the December 2021 quarter

Paushak rose 6.45% to Rs 10400.05, extending gains for the fourth trading session.

Paushak spurts 26% in four sessions

Hasn't fared well - amongst the low performers

Performance

Seems to be overvalued vs the market average

Valuation

Lagging behind the market in financials growth

Growth

Showing good signs of profitability & efficiency

Profitability

The stock is overpriced but is not in the overbought zone

Current price is more than the intrinsic value

Fundamentals

Good time to consider, stock is not in the overbought zone

Technicals

Entry point

Promoter pledged holding

Unsolicited messages

Default probability

Red flags

Paushak Limited is an India-based pharmaceutical company, which is engaged in the development and manufacturing of phosgene-based specialty chemicals and intermediates. 

Paushak Ltd